These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6995653)

  • 1. Effect of 3-hydrazino-6[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) on renin in hypertensive rats.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1980 Feb; 30(1):116-8. PubMed ID: 6995653
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive and antidiuretic effects of 3-hydrazino-6-[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) in rats.
    Watanabe TX; Shiono K; Saito K; Sokabe H
    Jpn J Pharmacol; 1978 Jun; 28(3):413-22. PubMed ID: 702944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
    Bellasio E; Campi A
    Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.
    Assandri A; Perazzi A; Buniva G; Pagani V
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):75-82. PubMed ID: 488135
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150.
    Maseri A; Pesola A; L'Abbate A; Contini C; Magini G
    J Int Med Res; 1976; 4(6):402-9. PubMed ID: 1027634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
    Beretta E; Cristina T; Ferrari P; Tuan G; Zerilli LF; Martinelli E
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):29-33. PubMed ID: 38122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
    Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
    Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)].
    Salzmann R; Bürki H; Chu D; Clark B; Marbach P; Markstein R; Reinert H; Siegl H; Waite R
    Arzneimittelforschung; 1979; 29(12):1843-53. PubMed ID: 232662
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat.
    Pettinger WA; Campbell WB; Keeton K
    Circ Res; 1973 Jul; 33(1):82-6. PubMed ID: 4765702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)].
    Baldoli E; Sardi A; Caravaggi AM; Bianchi G
    Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of 3-hydrazine-6[N,N-bis(2-hydroxyethyl)-amino]-pyridazine dihydrochloride (L6150) on the general and cardiac haemodynamics of the intact dog.
    Maxwell GM
    Clin Exp Pharmacol Physiol; 1976; 3(4):343-8. PubMed ID: 975622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term study of oxdralazine in hypertensive patients.
    Salvadeo A; Villa G; Segagni S; Criscuolo D
    Arzneimittelforschung; 1979; 29(11):1753-5. PubMed ID: 396926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
    De Ponti C; Bardi U; Marchetti M
    Arzneimittelforschung; 1976; 26(11):2089-92. PubMed ID: 1037254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of a new vasodilator antihypertensive agent endralazine (BQ 22708).
    Oates HF
    Med J Aust; 1980 Apr; 1(8):393. PubMed ID: 7393091
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridazine derivatives, VIII: Synthesis and antihypertensive activity of 6-(2-thienyl)-5-aminomethyl-3-hydrazino-pyridazines.
    Ravina E; Teran C; Dominguez NG; Masaguer CF; Gil-Longo J; Orallo F; Calleja JM
    Arch Pharm (Weinheim); 1991 Jul; 324(7):455-60. PubMed ID: 1763955
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
    Salzmann R; Gerber W; Pally C; Scholtysik G
    J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of blood pressure effects of nipradilol and prizidilol in normotensive and spontaneously hypertensive rats.
    Watanabe TX; Sokabe H; Kawashima K
    Jpn J Pharmacol; 1985 Jul; 38(3):273-9. PubMed ID: 3903298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin and the therapy of hypertension.
    Guthrie GP; Genest J; Kuchel O
    Annu Rev Pharmacol Toxicol; 1976; 16():287-308. PubMed ID: 779617
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives.
    Ravina E; Fueyo J; Teran C; Cid J; Garcia Mera G; Orallo F; Bardan B
    Pharmazie; 1992 Aug; 47(8):574-7. PubMed ID: 1438508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.